Ron Aldridge | executive |
Matthew Klein | executive |
Eric Pauwels | executive |
Kylie O'Keefe | executive |
Pierre Gravier | executive |
Kristen Kluska | analyst |
Eric Joseph | analyst |
Dingding Shi | analyst |
Brooke Schuster Gray | analyst |
Joseph Thome | analyst |
Huidong Wang | analyst |
David Lebowitz | analyst |
Good day, and thank you for standing by. Welcome to the PTC Therapeutics Second Quarter 2024 Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Ron Aldridge, Senior Director of Investor Relations.
Good afternoon, and thank you for joining us today to discuss PTC Therapeutics' Second Quarter 2024 Corporate Update and Financial Results.